Embryonal rhabdomyosarcoma in a child exposed to chemotherapy in utero: a mere coincidence?
Obstetrics and Gynaecology Department, CHUV-Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. Electronic address: anna.surbone@chuv.ch.
A
A
Surbone
Obstetrics and Gynaecology Department, CHUV-Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
C
C
Achtari
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000601:surgery; D002675:Child, Preschool; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000009:adverse effects*; D017239:Paclitaxel; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy; D011297:Prenatal Exposure Delayed Effects; D012074:Remission Induction; D012186:Retroperitoneal Neoplasms / Q000139:chemically induced* / Q000188:drug therapy; D018233:Rhabdomyosarcoma, Embryonal / Q000139:chemically induced* / Q000188:drug therapy; D043823:Taxoids / Q000009:adverse effects / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000601:surgery
D043823:Taxoids; D017239:Paclitaxel; D002945:Cisplatin